Cite Filings / DNTH / 0001897612-26-000577

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Dianthus Therapeutics, Inc. /DE/ Filed 2026-08-07 Acc 0001897612-26-000577

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-08-07 144 Sale of Securities
2026-08-07 144 Sale of Securities
2026-08-07 144 Sale of Securities
2026-08-07 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-08-07 4 CEO AND PRESIDENT sold 166,000 shares at an average $108.11 ($17,945,451)
2026-07-28 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…